Who Owns Ernexa Therapeutics Stock?
NASDAQ: ERNAHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 2.18%
- Held by insiders
- 29.53%
- Institutional holders
- 10
- Institutions 2.2%
- Insiders 29.5%
- Public and other 68.3%
Who owns Ernexa Therapeutics stock?
Institutional investors own about 2.2% of Ernexa Therapeutics's shares, spread across 10 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 29.53% of ERNA.
The largest institutional holders are Citadel Advisors Llc (0.93%), Vanguard Fiduciary Trust Co (0.51%) and Dauntless Investment Group, LLC (0.37%). Together, the top 9 institutions control 2.2% of shares outstanding. In their latest filings, 6 of the top 9 institutions increased their ERNA positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ERNA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Citadel Advisors Llc | 15.10K | 0.93% | +1041.7% |
| Vanguard Fiduciary Trust Co | 8.34K | 0.51% | +718.9% |
| Dauntless Investment Group, LLC | 6.00K | 0.37% | -75.5% |
| Vanguard Capital Management LLC | 5.68K | 0.35% | +436.2% |
| Tradewinds Capital Management, LLC | 361 | 0.02% | +100.0% |
| Blackrock Inc. | 33 | 0.00% | 0.0% |
| Assetmark, Inc. | 5 | 0.00% | 0.0% |
| SBI Securities Co., Ltd. | 1 | 0.00% | +100.0% |
| BNP Paribas Financial Markets | 1 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ERNA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 5.68K | 0.35% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 5.57K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.60K | 0.10% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 1 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Ernexa Therapeutics?
Citadel Advisors Llc is the largest institutional shareholder of ERNA, owning 0.93% of shares outstanding (15.10K shares) as of its latest 13F filing.
What percentage of Ernexa Therapeutics is owned by institutions?
Institutions own about 2.2% of ERNA shares and 3.1% of the public float.
How much of Ernexa Therapeutics do insiders own?
Insiders, such as officers and directors, own about 29.53% of ERNA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.